tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INKT Stock Latest News

MiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial
The FlyMiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial
22d ago
INKT
MiNK Therapeutics announces board resignation amid public appointment
PremiumCompany Announcements
MiNK Therapeutics announces board resignation amid public appointment
28d ago
8K
INKT
MiNK Therapeutics announces publication of new preclinical data for MiNK-215
PremiumThe Fly
MiNK Therapeutics announces publication of new preclinical data for MiNK-215
2M ago
INKT
MiNK Therapeutics Advances iNKT Platform in Q3 2025
PremiumCompany Announcements
MiNK Therapeutics Advances iNKT Platform in Q3 2025
3M ago
INKT
MiNK Therapeutics Earnings Call: Positive Sentiment and Promising Future
PremiumCompany Announcements
MiNK Therapeutics Earnings Call: Positive Sentiment and Promising Future
3M ago
INKT
MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases
PremiumRatingsMiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases
3M ago
INKT
MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year
Premium
The Fly
MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year
3M ago
INKT
INKT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INKT Upcoming Earnings Report: What to Expect?
3M ago
INKT
MiNK Therapeutics files $150M mixed securities shelf
PremiumThe Fly
MiNK Therapeutics files $150M mixed securities shelf
3M ago
INKT
Promising Phase 1 Results for MiNK Therapeutics’ agenT-797 Support Buy Rating
PremiumRatings
Promising Phase 1 Results for MiNK Therapeutics’ agenT-797 Support Buy Rating
3M ago
INKT
MiNK Therapeutics reports updated clinical results on agenT-797
PremiumThe Fly
MiNK Therapeutics reports updated clinical results on agenT-797
3M ago
INKT
MiNK Therapeutics Appoints Dr. John Holcomb as Director
PremiumCompany Announcements
MiNK Therapeutics Appoints Dr. John Holcomb as Director
4M ago
8K
INKT
MiNK Therapeutics appoints John Holcomb to board of directors
PremiumThe FlyMiNK Therapeutics appoints John Holcomb to board of directors
4M ago
INKT
MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases
Premium
The Fly
MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases
4M ago
INKT
Mink Therapeutics’ Earnings Call: Clinical Progress Amid Financial Challenges
Premium
Company Announcements
Mink Therapeutics’ Earnings Call: Clinical Progress Amid Financial Challenges
5M ago
INKT
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
6M ago
BJ
PH
MiNK Therapeutics: Promising Clinical Trials and Growth Prospects Lead to Buy Rating
PremiumRatings
MiNK Therapeutics: Promising Clinical Trials and Growth Prospects Lead to Buy Rating
6M ago
INKT
MiNK Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe Fly
MiNK Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
6M ago
INKT
MiNK Therapeutics Reports Q2 2025 Milestones and Financials
PremiumCompany Announcements
MiNK Therapeutics Reports Q2 2025 Milestones and Financials
6M ago
INKT
MiNK Therapeutics reports Q2 EPS ($1.06) vs (73c) last year
PremiumThe FlyMiNK Therapeutics reports Q2 EPS ($1.06) vs (73c) last year
6M ago
INKT
Mink Therapeutics, Inc. (INKT) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Mink Therapeutics, Inc. (INKT) Q2 Earnings Cheat Sheet
6M ago
INKT
H.C. Wainwright downgrades MiNK Therapeutics after 400% rally
Premium
The Fly
H.C. Wainwright downgrades MiNK Therapeutics after 400% rally
7M ago
INKT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >